Ixekizumab Biosimilar - Anti-IL17A mAb - Research Grade
Source
DrugBank DB11569
Species
Human
Expression system
Mammalian cells
Molecular weight
146kDa
Purity
>85%
Buffer
PBS pH7.5
Delivery condition
Blue ice (+4°C)
Delivery Time
3-5 days if in stock; 3-5 weeks if production needed
Storage condition
4°C for short term; -20°C for long term
Brand
ProteoGenix
Aliases /Synonyms
Ixekizumab,Ixekizumab,IL17A,anti-IL17A
Reference
PX-TA1022
Note
For research use only. Not suitable for clinical or therapeutic use.
Isotype
IgG4Kappa
Clonality
Monoclonal Antibody
Description of Ixekizumab Biosimilar - Anti-IL17A mAb - Research Grade
General information about Ixekizumab
Recombinant monoclonal antibody to IL17A. Ixekizumab is a humanized monoclonal antibody used in the treatment of autoimmune diseases. This product is for research use only.
SDS-PAGE for Ixekizumab Biosimilar - Anti-IL17A mAb
Ixekizumab Biosimilar - Anti-IL17A mAb on SDS-PAGE under reducing (left figure) and non-reducing (right figure) conditions. The gel was stained overnight with Coomassie Blue. The purity of the antibody is superior than 90 %.
Ixekizumab Biosimilar - Anti-IL17A mAb binds to IL17A, C-His, recombinant protein in indirect ELISA Assay
Immobilized IL17A, C-His, recombinant protein (cat. No.PX-P5780) at 0.5µg/mL (100µL/well) can bind to Ixekizumab Biosimilar - Anti-IL17A mAb (cat. No.PX-TA1022) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450
Reviews
There are no reviews yet.
REVIEW YOUR PRODUCT
Be the first to review “Ixekizumab Biosimilar – Anti-IL17A mAb – Research Grade” Cancel reply
Reviews
There are no reviews yet.